Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01115907 · ClinicalTrials.gov registry record · Phase 3
Freedom SOLO Stentless Heart Valve Study
A Phase 3 study, sponsored by Sorin Group USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 251
- Enrollment target
NCT01115907 is a Phase 3 study that has completed, run by Sorin Group USA. The registered enrollment target is 251 participants.
The verdict
NCT01115907, a Phase 3 study, has completed, sponsored by Sorin Group USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 251 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to demonstrate the safety and effectiveness of the Freedom SOLO heart valve.
Interventions
- DEVICE Freedom SOLO Stentless Heart Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01115907
The ClinicalTrials.gov registry entry for NCT01115907 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sorin Group USA, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Freedom SOLO Stentless Heart Valve is the first listed.
NCT01115907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01115907 about?
NCT01115907 is a clinical study titled "Freedom SOLO Stentless Heart Valve Study". The purpose of this clinical investigation is to demonstrate the safety and effectiveness of the Freedom SOLO heart valve.
What is the current status of trial NCT01115907?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 251 participants. The study started on 2010-12. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01115907?
The interventions under investigation include: Freedom SOLO Stentless Heart Valve (DEVICE).
Who is sponsoring clinical trial NCT01115907?
This trial is sponsored by Sorin Group USA, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.